» Articles » PMID: 6298469

Transcription of Mouse Mammary Tumor Virus: Identification of a Candidate MRNA for the Long Terminal Repeat Gene Product

Overview
Journal J Virol
Date 1983 Apr 1
PMID 6298469
Citations 25
Authors
Affiliations
Soon will be listed here.
Abstract

We have examined an assortment of preneoplastic and neoplastic mouse mammary tissues for the presence of an mRNA which could encode the putative long terminal repeat gene product of mouse mammary tumor virus. We report here the detection of a novel mouse mammary tumor virus-specific, polyadenylic acid-containing transcript in certain preneoplastic and neoplastic mammary tissue of BALB/c mice. The molecule is 1.6 kilobases in length and contains sequences from the transcriptional leader and the U3 region of the proviral DNA. The upstream terminus of the 3' information lies 75 to 80 nucleotides from the beginning of the long terminal repeat open reading frame, in close proximity to a consensus splice acceptor in the DNA. The transcript was detected in hormonally or chemically induced neoplastic, preneoplastic, and lactating mammary tissue of BALB/c mice, but not in preneoplastic or tumor tissue induced by exogenous viruses in any strain of mice examined. This implies that the RNA we observed is transcribed from an endogenous provirus template.

Citing Articles

Convergent capture of retroviral superantigens by mammalian herpesviruses.

Aswad A, Katzourakis A Nat Commun. 2015; 6:8299.

PMID: 26400439 PMC: 4667437. DOI: 10.1038/ncomms9299.


C3H mouse mammary tumor virus superantigen function requires a splice donor site in the envelope gene.

Mustafa F, Lozano M, Dudley J J Virol. 2000; 74(20):9431-40.

PMID: 11000212 PMC: 112372. DOI: 10.1128/jvi.74.20.9431-9440.2000.


Expression of mouse mammary tumor virus superantigen mRNA in the thymus correlates with kinetics of self-reactive T-cell loss.

Barnett A, Mustafa F, Wrona T, Lozano M, Dudley J J Virol. 1999; 73(8):6634-45.

PMID: 10400761 PMC: 112748. DOI: 10.1128/JVI.73.8.6634-6645.1999.


Negative-acting factor and superantigen are separable activities of the mouse mammary tumor virus long terminal repeat.

Wintersperger S, Salmons B, Miethke T, Erfle V, Wagner H, Gunzburg W Proc Natl Acad Sci U S A. 1995; 92(7):2745-9.

PMID: 7708717 PMC: 42295. DOI: 10.1073/pnas.92.7.2745.


Increased concentration of an indigenous proviral mouse mammary tumor virus long terminal repeat-containing transcript is associated with neoplastic transformation of mammary epithelium in C3H/Sm mice.

Graham D, Medina D, Smith G J Virol. 1984; 49(3):819-27.

PMID: 6321767 PMC: 255543. DOI: 10.1128/JVI.49.3.819-827.1984.


References
1.
Medina D, DeOME K . Influence of mammary tumor virus on the tumor-producing capabilities of nodule outgrowth free of mammary tumor virus. J Natl Cancer Inst. 1968; 40(6):1303-8. View

2.
Schlom J, Michalides R, Kufe D, Hehlmann R, Spiegelman S, Bentvelzen P . A comparative study of the biologic and molecular basis of murine mammary carcinoma: a model for human breast cancer. J Natl Cancer Inst. 1973; 51(2):541-51. View

3.
Jamjoom G, Naso R, Arlinghaus R . Further characterization of intracellular precursor polyproteins of Rauscher leukemia virus. Virology. 1977; 78(1):11-34. DOI: 10.1016/0042-6822(77)90075-7. View

4.
Rigby P, Dieckmann M, Rhodes C, Berg P . Labeling deoxyribonucleic acid to high specific activity in vitro by nick translation with DNA polymerase I. J Mol Biol. 1977; 113(1):237-51. DOI: 10.1016/0022-2836(77)90052-3. View

5.
Deeley R, Gordon J, Burns A, Mullinix K, Binastein M, Goldberg R . Primary activation of the vitellogenin gene in the rooster. J Biol Chem. 1977; 252(22):8310-9. View